Genmab A/S’ 2023 Annual General Meeting took place on Wednesday, March 29, 2023, at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, 1560 Copenhagen V, Denmark.
To replay the webcast of the Annual General Meeting, please use one of the following links:
Please click on the links below for information concerning Genmab A/S’ Annual General Meeting 2023
• Shareholder letter
• Notice of Annual General Meeting 2023 with agenda, including Appendix 1: Candidates for the Board of Directors, and Appendix 2: Proposed amended Remuneration Policy
• Register online or use the registration form
• Submit proxy or postal vote online or use the form to submit proxy or postal vote
• 2022 Annual Report of Genmab A/S
• 2022 Compensation Report
The total number of voting rights and total share capital per February 23, 2023, are:
Total Number of Voting Rights: 65,961,573
Total Share Capital: 65,961,573
Questions regarding registration to participate may be directed to Euronext Securities at tel. no. (+45) 43 58 88 66 or [email protected].
Vice President,
Head of Investor Relations
Telephone: +45 3377 9558
Email: [email protected]
Kalvebod Brygge 43
1560 Copenhagen V
Denmark
We process your personal data in accordance with applicable rules. Please click here to read our Privacy Policy.
Please note that Genmab A/S, as a general rule, no longer sends the calling to Annual General Meetings by postal mail. If you wish to receive the invitation to future Annual General Meetings via e-mail, please register your e-mail address at the InvestorPortal. If you do not have access to an e-mail address, please contact Euronext Securities at: (+45) 43 58 88 66.
Read about Genmab’s purpose, core values and key accomplishments
See the results of innovation that is rooted in science
We are developing next-generation technologies